Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels

por Benjamin, Silas, Ramanjaneya, Manjunath, Butler, Alexandra E., Janjua, Imran, Paramba, Firjeeth, Palaki, Jafer, Kubaisi, Aisha Al, Chandra, Prem, Abdalhakam, Ibrahem, Massodi, Nasseer Ahmad
Publicado 2021